Olangcaya, Abdul .

HRN: 20-06-52  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/09/2026
TENOFOVIR DISOPROXIL FUMARATE 300MG TAB
06/09/2026
06/29/2026
ORAL
300mg
OD
Hep B Infection
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines